QuickView for malate dehydrogenase 4 (biogroup)

1. Lean and obese B6 and BTBR mice aged 4 weeks and 10 weeks
2. L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens
3. Adipose tissue, adipocytes and stromal-vascular pellet cells from multiple body regions
4. B cell populations after immune activation
5. Gastric enterochromaffin-like (ECL) and parietal (PCL) cells from rats after 24hr fasting

There were no matches for malate dehydrogenase 4

1. Sunitinib Malate and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have No…
2. Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metast…
3. Special Investigation For Renal Cell Carcinoma (RCC) Of Sunitinib Malate (Regulatory Post Marketing …
4. Sunitinib Malate to Treat Advanced Eye Disease in Patients With Von Hippel-Lindau Syndrome
5. Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metas…